D-dimer to Guide Anticoagulation Therapy in Patients With Atrial Fibrillation

• Status: Unknown status
• Trial end date: 2020-05-30
• Target enrollment: 0
• Participant gender: All

Summary

This was a prospective, three arms, randomized controlled study.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wuhan Asia Heart Hospital
• Treatments: Dabigatran; Fibrin fragment D; Warfarin

Criteria

Inclusion Criteria:

• Patients with non-valvular atrial fibrillation

• Receiving warfarin therapy

Exclusion Criteria:

• Patients who had suffered from recent (within 3 months) myocardial infarction, ischemic stroke, deep vein thrombosis, cerebral hemorrhages, or other serious diseases.

• Those who had difficulty in compliance or were unavailable for follow-up.